SEC Comment Letter for ANAVEX LIFE SCIENCES CORP. (AVXL) (CIK 0001314052) (AVXL) — Jul 11, 2019
ANAVEX LIFE SCIENCES CORP. (AVXL) (CIK 0001314052)
Date: July 11, 2019 · CIK: 0001314052 · Accession: 0000000000-19-011025
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-232550
Letter
July 11, 2019 Christopher Missling Chief Executive Officer Anavex Life Sciences Corp. 51 West 52nd Street, 7th Floor New York, NY 10019-6163 Re:Anavex Life Sciences Corp. Registration Statement on Form S-3 Filed July 3, 2019 File No. 333-232550 Dear Mr. Missling: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Michael Killoy at 202-551-7576 with any questions. Sincerely, Division of Corporation Finance Office of Beverages, Apparel and Mining
Show Raw Text
July 11, 2019
Christopher Missling
Chief Executive Officer
Anavex Life Sciences Corp.
51 West 52nd Street, 7th Floor
New York, NY 10019-6163
Re:Anavex Life Sciences Corp.
Registration Statement on Form S-3
Filed July 3, 2019
File No. 333-232550
Dear Mr. Missling:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Michael Killoy at 202-551-7576 with any questions.
Sincerely,
Division of Corporation Finance
Office of Beverages, Apparel and
Mining